[1]Niromiya T, Yoon S, Sugano M, et al. Improvement of molar ratio of branched-chain amino acids to tyrosine (BTR) associated with liver fibrosis in chronic hepatitis C patients treated with interferon-alpha[J]. Dig Dis Sci, 1999, 44 (5) ∶1027-33.
|
[2] Suzuki H, Mamata Y, Tominaga T, et al. Influence of alcohol on branched-chain amino acid/tyrosine molar ratio in patients with cirrhosis[J].Alcohol Clin Exp Res, 1998, 22 (3 Suppl) ∶ 137S-140S.
|
[3]Marchesini G, Bianchi G, Brizi M, et al. Nutritional treatment with branched-chain amino acids in advanced liver cirrhosis[J]. J Gastroenterol, 2000, 35Suppl 12∶7-12.
|
[4]Kawamura Yasui N, Kaito M, Fujita N, et al. Evaluating response to nutritional therapy using the branched-chain amiro acid/tyrosine ratio in patients with chronic liver disease[J]. J Clin Lab Anal, 1999, 13 (1) ∶31-4.
|
[1] | Branch of Hepatobiliary Diseases, Chinese Association of Chinese Medicine. The standards of traditional Chinese medicine syndrome differentiation for viral hepatitis[J]. Journal of Clinical Hepatology, 2017, 33(10): 1839-1846. doi: 10.3969/j.issn.1001-5256.2017.10.002 |
[3] | Jin XueYuan, Lou Min, Zhao Ping, Long SuYun. Clinical significance of the serum neopterin detection in patients with chronic viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 90-91. |
[5] | Tao Hu, Gao Tao, Xu Bin. Revaluate the clinical significance of serum transferrin changes in patients with hepatitis[J]. Journal of Clinical Hepatology, 2004, 20(3): 148-149. |
[6] | He DongGou, Chen BoMing, Lin YongPing. Research of T lymphocyte subtypes and the phagocytosis activity of macrophages in the patients with virul hepatitis[J]. Journal of Clinical Hepatology, 2000, 16(1): 30-31. |
[7] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |